Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells

The prognosis of gioblastoma, the standard chemotherapy agent for which is temozolomide (TMZ), remains poor despite recent advances in multimodal treatments. Therefore, it is necessary to identify and develop novel therapeutics for this malignant disease. Ribavirin, an anti-viral agent which is one...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Ochiai, Yushi, Sumi, Koichiro, Sano, Emiko, Yoshimura, Sodai, Yamamuro, Shun, Ogino, Akiyoshi, Ueda, Takuya, Suzuki, Yutaka, Nakayama, Tomohiro, Hara, Hiroyuki, Katayama, Yoichi, Yoshino, Atsuo
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2020
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475644/
https://ncbi.nlm.nih.gov/pubmed/32934745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12039
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars